Healthcare Wire Hong Kong: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Hong Kong.

Press releases published on August 27, 2026

15 minutes ago

Alvotech to present at upcoming investor conferences in September

Indeterminate GlobeNewswire

15 minutes ago

Noah Medical Announces Collaboration to Advance Imaging in Robotic-Assisted Bronchoscopy

Indeterminate GlobeNewswire

15 minutes ago

SL Science Highlights New FDA Drug Master File for GDT Cell-Derived Exosomes, Expanding the Regulatory Foundation of its Platform

Indeterminate GlobeNewswire

15 minutes ago

Artelo Biosciences Announces Reverse Stock Split

Indeterminate GlobeNewswire

15 minutes ago

CytomX Therapeutics Announces FDA Fast Track Designation for Varsetatug masetecan (“Varseta-M”) for Relapsed/Refractory Metastatic Colorectal Cancer (R/R mCRC)

Indeterminate GlobeNewswire

15 minutes ago

Milestone Pharmaceuticals Announces Data Presented at ESC Congress 2026 on the Impact of Paroxysmal Supraventricular Tachycardia (PSVT) on Patients’ Daily Lives and Quality of Life Between Episodes

Indeterminate GlobeNewswire

15 minutes ago

MBX Biosciences Announces First Patient Dosed in Pivotal Phase 3 oPTimize Trial of Once-Weekly Canvuparatide in Adults with Hypoparathyroidism

Indeterminate GlobeNewswire

15 minutes ago

Cardurion Pharmaceuticals Announces Late-Breaking Presentation of Phase 2 Results for Tovinontrine (CRD-750), a PDE9 Inhibitor, in Heart Failure

Indeterminate GlobeNewswire

15 minutes ago

HealthEquity Reports Second Quarter Ended July 31, 2026 Financial Results

Indeterminate GlobeNewswire

15 minutes ago

Verrica Pharmaceuticals Announces Completion of Enrollment in First Pivotal Phase 3 Trial (COVE-2) Evaluating YCANTH® for the Treatment of Common Warts, with Topline Data Expected Q1 2027

Indeterminate GlobeNewswire

15 minutes ago

Catheter Precision Achieves Major Commercial Milestones with Cardinal Health, Johns Hopkins and the placement of the First VIVO System in Germany

Indeterminate GlobeNewswire

15 minutes ago

Rectify Pharmaceuticals Presents Discovery of Clinical Candidate RTY-406, a Novel Disease-Modifying Therapy for the Treatment of PSC at ACS Fall 2026 Meeting

Indeterminate GlobeNewswire

15 minutes ago

Pluri Announces Pricing of $3.3 Million Registered Direct Offering and Concurrent Private Placement with a Single Healthcare Focused Institutional Investor

Indeterminate GlobeNewswire

15 minutes ago

Entera to Participate in Upcoming Fall Investor Conferences

Indeterminate GlobeNewswire

15 minutes ago

Eascra Biotech Awarded $7.96 Million NASA InSPA Phase 2 Contract to Advance Space-Manufactured Nanomedicine

Indeterminate GlobeNewswire

15 minutes ago

Eascra Biotech Appoints Chief Scientific Officer to Lead Commercialization Push

Indeterminate GlobeNewswire

40 minutes ago

Bioprinting Market to Reach $5.1 Billion by 2030, Driven by Regenerative Medicine Demand and AI Integration

Indeterminate GlobeNewswire

an hour ago

BrainsWay Deep TMS™ Study Shows 70% Reduction in Patients Experiencing Suicidal Ideation

Indeterminate GlobeNewswire

an hour ago

Corvus Pharmaceuticals Announces Publication in Blood of Final Phase 1 Data from the Soquelitinib Phase 1/1b T Cell Lymphoma Trial

Indeterminate GlobeNewswire

an hour ago

Nexalin Technology Announces Reverse Stock Split

Indeterminate GlobeNewswire